211 related articles for article (PubMed ID: 33682475)
1. Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data.
Simon ST; Mandair D; Tiwari P; Rosenberg MA
J Cardiovasc Pharmacol Ther; 2021 Jul; 26(4):335-340. PubMed ID: 33682475
[TBL] [Abstract][Full Text] [Related]
2. Interpretable Machine Learning Prediction of Drug-Induced QT Prolongation: Electronic Health Record Analysis.
Simon ST; Trinkley KE; Malone DC; Rosenberg MA
J Med Internet Res; 2022 Dec; 24(12):e42163. PubMed ID: 36454608
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning Techniques Outperform Conventional Statistical Methods in the Prediction of High Risk QTc Prolongation Related to a Drug-Drug Interaction.
Van Laere S; Muylle KM; Dupont AG; Cornu P
J Med Syst; 2022 Nov; 46(12):100. PubMed ID: 36418746
[TBL] [Abstract][Full Text] [Related]
4. Development of a predictive model for drug-associated QT prolongation in the inpatient setting using electronic health record data.
Hincapie-Castillo JM; Staley B; Henriksen C; Saidi A; Lipori GP; Winterstein AG
Am J Health Syst Pharm; 2019 Jul; 76(14):1059-1070. PubMed ID: 31185072
[TBL] [Abstract][Full Text] [Related]
5. Assessment of a Machine Learning Model Applied to Harmonized Electronic Health Record Data for the Prediction of Incident Atrial Fibrillation.
Tiwari P; Colborn KL; Smith DE; Xing F; Ghosh D; Rosenberg MA
JAMA Netw Open; 2020 Jan; 3(1):e1919396. PubMed ID: 31951272
[TBL] [Abstract][Full Text] [Related]
6. Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review.
Tomaselli Muensterman E; Tisdale JE
Pharmacotherapy; 2018 Aug; 38(8):813-821. PubMed ID: 29882591
[TBL] [Abstract][Full Text] [Related]
7. An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval.
Lorberbaum T; Sampson KJ; Woosley RL; Kass RS; Tatonetti NP
Drug Saf; 2016 May; 39(5):433-41. PubMed ID: 26860921
[TBL] [Abstract][Full Text] [Related]
8. Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
Giudicessi JR; Schram M; Bos JM; Galloway CD; Shreibati JB; Johnson PW; Carter RE; Disrud LW; Kleiman R; Attia ZI; Noseworthy PA; Friedman PA; Albert DE; Ackerman MJ
Circulation; 2021 Mar; 143(13):1274-1286. PubMed ID: 33517677
[TBL] [Abstract][Full Text] [Related]
9. Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugs.
Bindraban AN; Rolvink J; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
Int J Clin Pharm; 2018 Oct; 40(5):1372-1379. PubMed ID: 30051227
[TBL] [Abstract][Full Text] [Related]
10. QTNet: Predicting Drug-Induced QT Prolongation With Artificial Intelligence-Enabled Electrocardiograms.
Zhang H; Tarabanis C; Jethani N; Goldstein M; Smith S; Chinitz L; Ranganath R; Aphinyanaphongs Y; Jankelson L
JACC Clin Electrophysiol; 2024 May; 10(5):956-966. PubMed ID: 38703162
[TBL] [Abstract][Full Text] [Related]
11. Prediction of incident myocardial infarction using machine learning applied to harmonized electronic health record data.
Mandair D; Tiwari P; Simon S; Colborn KL; Rosenberg MA
BMC Med Inform Decis Mak; 2020 Oct; 20(1):252. PubMed ID: 33008368
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.
Tisdale JE; Jaynes HA; Kingery JR; Mourad NA; Trujillo TN; Overholser BR; Kovacs RJ
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):479-87. PubMed ID: 23716032
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
[TBL] [Abstract][Full Text] [Related]
15. Incidence and outcomes of long QTc in acute medical admissions.
Mahmud R; Gray A; Nabeebaccus A; Whyte MB
Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
[TBL] [Abstract][Full Text] [Related]
16. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
17. Impact of left ventricular hypertrophy on QT prolongation and associated mortality.
Haugaa KH; Bos JM; Borkenhagen EJ; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ
Heart Rhythm; 2014 Nov; 11(11):1957-65. PubMed ID: 24956189
[TBL] [Abstract][Full Text] [Related]
18. An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology.
Alahmadi A; Davies A; Royle J; Goodwin L; Cresswell K; Arain Z; Vigo M; Jay C
Comput Biol Med; 2021 Apr; 131():104281. PubMed ID: 33636421
[TBL] [Abstract][Full Text] [Related]
19. Institution-wide QT alert system identifies patients with a high risk of mortality.
Haugaa KH; Bos JM; Tarrell RF; Morlan BW; Caraballo PJ; Ackerman MJ
Mayo Clin Proc; 2013 Apr; 88(4):315-25. PubMed ID: 23541006
[TBL] [Abstract][Full Text] [Related]
20. Coupling Data Mining and Laboratory Experiments to Discover Drug Interactions Causing QT Prolongation.
Lorberbaum T; Sampson KJ; Chang JB; Iyer V; Woosley RL; Kass RS; Tatonetti NP
J Am Coll Cardiol; 2016 Oct; 68(16):1756-1764. PubMed ID: 27737742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
